SUPN
NASDAQ · Pharmaceuticals
Supernus Pharmaceuticals Inc
$26.21
-0.53 (-1.98%)
Performance
1D
—
1W
-27.76%
1M
-26.85%
3M
-31.87%
6M
-31.53%
1Y
-15.12%
YTD
-26.64%
Open$26.65
Previous Close$26.74
Day High$27.09
Day Low$26.15
52W High$59.68
52W Low$26.52
Volume—
Avg Volume3.94M
Market Cap5.55B
P/E Ratio16.15
EPS$2.73
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$34.69
Below
SMA 200
$35.61
Below
RSI (14)
31.2
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
11 analysts
Price Target
+246.5% upside
Current
$26.21
$26.21
Target
$90.83
$90.83
$64.19
$90.83 avg
$118.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.19B | 1.16B | 1.12B |
| Net Income | 347.68M | 305.22M | 218.96M |
| Profit Margin | 29.2% | 27.8% | 19.5% |
| EBITDA | 433.79M | 401.97M | 345.29M |
| Free Cash Flow | — | — | 147.80M |
| Rev Growth | +2.5% | +2.5% | +10.9% |
| Debt/Equity | 0.45 | 0.45 | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |